Work

AMD107: Efficacy as a Selective Inhibitor of the Tyrosine Kinase Activity of BCR-ABL in Murine Leukemia Models.

Year: 2004

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood.v104.11.551.551

Authors: James D. Griffin, Doriano Fabbro, Gabriele Fendrich, Brian Huntly, Sandra Jacob, Andrew Kung, Jurgen Mestan, Ellen Weisberg, D. Gary Gilliland, Paul W. Manley

Institutions: Dana-Farber Cancer Institute, Novartis Institutes for BioMedical Research, Brigham and Women's Hospital

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2559877690

Cites:

Cited by: 2

Related to: 10